scholarly journals Photodynamic inactivation of microorganisms sensitized by cationic BODIPY derivatives potentiated by potassium iodide

2017 ◽  
Vol 16 (10) ◽  
pp. 1524-1536 ◽  
Author(s):  
Eugenia Reynoso ◽  
Ezequiel D. Quiroga ◽  
Maximiliano L. Agazzi ◽  
María B. Ballatore ◽  
Sonia G. Bertolotti ◽  
...  

Photoinactivation of microbial cells mediated by BODIPYs 3 and 4 was potentiated by the addition of potassium iodide.

2017 ◽  
Vol 3 (4) ◽  
pp. 320-328 ◽  
Author(s):  
Liyi Huang ◽  
Grzegorz Szewczyk ◽  
Tadeusz Sarna ◽  
Michael R. Hamblin

2019 ◽  
Vol 11 (18) ◽  
pp. 2427-2445 ◽  
Author(s):  
Michael R Hamblin ◽  
Heidi Abrahamse

Tetracyclines are well established antibiotics but show phototoxicity as a side effect. Antimicrobial photodynamic inactivation uses nontoxic dyes combined with harmless light to destroy microbial cells by reactive oxygen species. Tetracyclines (demeclocycline and doxycycline) can act as light-activated antibiotics by binding to bacterial cells and killing them only upon illumination. The remaining tetracyclines can prevent bacterial regrowth after illumination has ceased. Antimicrobial photodynamic inactivation can be potentiated by potassium iodide. Azide quenched the formation of iodine, but not hydrogen peroxide. Demeclotetracycline (but not doxycycline) iodinated tyrosine after light activation in the presence of potassium iodide. Bacteria are killed by photoactivation of tetracyclines in the absence of oxygen. Since topical tetracyclines are already used clinically, blue light activation may increase the bactericidal effect.


2015 ◽  
Vol 59 (9) ◽  
pp. 5203-5212 ◽  
Author(s):  
Daniela Vecchio ◽  
Asheesh Gupta ◽  
Liyi Huang ◽  
Giacomo Landi ◽  
Pinar Avci ◽  
...  

ABSTRACTThe inexorable increase of antibiotic resistance occurring in different bacterial species is increasing the interest in developing new antimicrobial treatments that will be equally effective against multidrug-resistant strains and will not themselves induce resistance. One of these alternatives may be photodynamic inactivation (PDI), which uses a combination of nontoxic dyes, called photosensitizers (PS), excited by harmless visible light to generate reactive oxygen species (ROS) by type 1 (radical) and type 2 (singlet oxygen) pathways. In this study, we asked whether it was possible to improve the efficacy of PDIin vitroandin vivoby addition of the inert salt potassium iodide (KI) to a commonly investigated PS, the phenothiazinium dye methylene blue (MB). By adding KI, we observed a consistent increase of red light-mediated bacterial killing of Gram-positive and Gram-negative speciesin vitroandin vivo. In vivo, we also observed less bacterial recurrence in wounds in the days posttreatment. The mechanism of action is probably due to formation of reactive iodine species that are produced quickly with a short lifetime. This finding may have a relevant clinical impact by reducing the risk of amputation and, in some cases, the risk of death, leading to improvement in the care of patients affected by localized infections.


2020 ◽  
Vol 19 (8) ◽  
pp. 1063-1071
Author(s):  
Kelly A. D. F. Castro ◽  
Guilherme T. P. Brancini ◽  
Letícia D. Costa ◽  
Juliana C. Biazzotto ◽  
M. Amparo F. Faustino ◽  
...  

Co-encapsulation of a neutral porphyrin photosensitizer (designated as P1) and KI into micelles in combination with visible light to produce ROS and iodine is a promising approach for increasing the efficiency of PDT treatment.


Sign in / Sign up

Export Citation Format

Share Document